Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac

@inproceedings{Kristiansen2014PersistentLC,
  title={Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac},
  author={Paul A. Kristiansen and Absatou Ky Ba and A S Ou{\'e}draogo and Idrissa Sanou and Rasmata Ou{\'e}draogo and Lassana Sangar{\'e} and Fabien V.K. Diomand{\'e} and Denis Kandolo and Inger Marie Saga and Lara K. Misegades and Thomas A. Clark and Marie-Pierre Pr{\'e}ziosi and Dominique A Caugant},
  booktitle={BMC infectious diseases},
  year={2014}
}
BACKGROUND The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In repeated multicentre cross-sectional studies in Burkina Faso we demonstrated a significant effect of vaccination on NmA carriage for one year following mass vaccination in 2010. A new multicentre carriage study was performed in October-November 2012, two years after MenAfriVac mass vaccination. METHODS Oropharyngeal samples… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

  • PA Kristiansen, F Diomandé, +18 authors DA Caugant
  • Clin Infect Dis
  • 2013
Highly Influential
20 Excerpts

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A Kristiansen et al. BMC Infectious Diseases

  • D Daugla, J Gami, +26 authors BM Greenwood
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…